Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -29.35% is 66% above its 5-year average of -86.61%, near the high end of its 5-year range (-4212.97%–46.41%).
97.69% above its 12-month average of -1270.63%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1677.08%.
OPERATING MARGIN
-29.35%
OPERATING MARGIN AVG TTM
-1270.63%
OPERATING MARGIN AVG 3Y
-30.84%
OPERATING MARGIN AVG 5Y
-86.61%
OPERATING MARGIN AVG 10Y
-134.12%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+97.69%
CURRENT VS 3Y AVG
+4.84%
CURRENT VS 5Y AVG
+66.11%
CURRENT VS 10Y AVG
+78.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CytomX Therapeutics, Inc.
Market Cap
$561.67M
Operating Margin
-29.35%
TTM Avg
-1270.63%
3Y Avg
-30.84%
5Y Avg
-86.61%
Market Cap
$569.56M
Operating Margin
46.95%
TTM Avg
-1.63%
3Y Avg
-11705.79%
5Y Avg
-12269.85%
Market Cap
$551.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$573.38M
Operating Margin
-156.36%
TTM Avg
-104.91%
3Y Avg
-81.98%
5Y Avg
-81.61%
Market Cap
$547.86M
Operating Margin
-1.90%
TTM Avg
-16.29%
3Y Avg
-781.66%
5Y Avg
-851.82%
Market Cap
$579.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$596.36M
Operating Margin
-975.91%
TTM Avg
-867.04%
3Y Avg
-586.91%
5Y Avg
-743.36%
Market Cap
$519.25M
Operating Margin
-230460.98%
TTM Avg
-373160.49%
3Y Avg
-159952.53%
5Y Avg
-107112.87%
Market Cap
$517.79M
Operating Margin
-1407.52%
TTM Avg
-703.76%
3Y Avg
-114341.22%
5Y Avg
-77223.74%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | $561.67M | -29.35% | -1270.63% | -30.84% | -86.61% |
| CorMedix Inc. (CRMD)vs › | $569.56M | 46.95% | -1.63% | -11705.79% | -12269.85% |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -156.36% | -104.91% | -81.98% | -81.61% |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | -1.90% | -16.29% | -781.66% | -851.82% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -975.91% | -867.04% | -586.91% | -743.36% |
| Altimmune, Inc. (ALT)vs › | $519.25M | -230460.98% | -373160.49% | -159952.53% | -107112.87% |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | -1407.52% | -703.76% | -114341.22% | -77223.74% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | 0.00% | -620906.82% | -450471.78% | -300340.85% |
Gross Margin
98.6%
Operating Margin
-29.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1677.08% |
| 2026-03-31 | -191.77% |
| 2025-12-31 | -4212.97% |
| 2025-09-30 | -264.43% |
| 2025-06-30 | -6.89% |
| 2025-03-31 | 44.43% |
| 2024-12-31 | 46.41% |
| 2024-09-30 | 12.30% |
| 2024-06-30 | -33.65% |
| 2024-03-31 | 28.11% |
| 2023-12-31 | -2.28% |
| 2023-09-30 | 42.04% |
| 2023-06-30 | -13.54% |
| 2023-03-31 | -24.06% |
| 2022-12-31 | -47.25% |
| 2022-09-30 | -266.53% |
| 2022-06-30 | -233.83% |
| 2022-03-31 | -354.67% |
| 2021-12-31 | -133.36% |
| 2021-09-30 | -128.74% |
| 2021-06-30 | -117.91% |
| 2021-03-31 | -97.85% |
| 2020-12-31 | -90.26% |
| 2020-09-30 | -83.74% |
| 2020-06-30 | -97.17% |
| 2020-03-31 | -5.63% |
| 2019-12-31 | -451.49% |
| 2019-09-30 | -240.09% |
| 2019-06-30 | -346.53% |
| 2019-03-31 | -56.18% |
| 2018-12-31 | -225.00% |
| 2018-09-30 | -185.28% |
| 2018-06-30 | -62.13% |
| 2018-03-31 | -110.19% |
| 2017-12-31 | -4.61% |
| 2017-09-30 | -45.66% |
| 2017-06-30 | -289.91% |
| 2017-03-31 | -73.92% |
| 2016-12-31 | -226.88% |
| 2016-09-30 | -431.85% |
| 2016-06-30 | -460.83% |
| 2016-03-31 | -727.94% |
| 2015-12-31 | -579.68% |
| 2015-09-30 | -581.18% |
| 2015-06-30 | -271.27% |
| 2015-03-31 | -279.45% |
| 2014-12-31 | -250.35% |
| 2014-09-30 | -180.89% |
| 2014-06-30 | -719.97% |
| 2014-03-31 | -2653.07% |
